Search Results - "Rahkama, V"

Precision systems medicine in urological Tumors – Molecular profiling and functional testing by Saeed, K., Ojamies, P., Pellinen, T., Rahkama, V., Eldfors, S., Paavolainen, L., Turkki, R., Horvath, P., Lundin, J., Nisen, H., af Hällström, T.M., Rannikko, A., Mirtti, T., Kallioniemi, O., Östling, P.

Get full text

FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide™) by Belikov, S., Öberg, C., Jääskeläinen, T., Rahkama, V., Palvimo, J.J., Wrange, Ö.

“…► The effect of bicalutamide is corrupted by FoxA1 while that of MDV3100 is reduced. ► MDV3100-AR complex binds specifically to the androgen response elements…”
Get full text

684: Helsinki Urological Biobank (HUB): A new-generation integrated biobank for facilitating precision medicine and translational research in urological cancers by Af Hällström, T, Mirtti, T, Saeed, K, Rahkama, V, Puhka, M, Ostling, P, Vesterinen, T, Pitkänen, K, Kallioniemi, O, Rannikko, A

Get full text

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer by Saeed, Khalid, Rahkama, Vesa, Eldfors, Samuli, Bychkov, Dmitry, Mpindi, John Patrick, Yadav, Bhagwan, Paavolainen, Lassi, Aittokallio, Tero, Heckman, Caroline, Wennerberg, Krister, Peehl, Donna M, Horvath, Peter, Mirtti, Tuomas, Rannikko, Antti, Kallioniemi, Olli, Östling, Päivi, af Hällström, Taija M

“…Abstract Background Technology development to enable the culture of human prostate cancer (PCa) progenitor cells is required for the identification of new,…”
Get full text